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Essential oil was extracted from leaves of Hyptis pectinata using hydrodistillation, and its composition determined using GC-FID 
and GC-MS. Chemical analysis showed that there was a predominance of sesquiterpenes, of which b-caryophyllene (18.34%), 
caryophyllene oxide (18.00%) and calamusenone (24.68%) were measured for the first time in the genus Hyptis. Twenty-one 
compounds were identified, and calamusenone was isolated using preparative thin layer chromatography with a silica gel plate (60 
PF254). The minimal inhibitory concentration (MIC) and minimal microbicidal concentration (MMC) were determined for various 
pathogenic microorganisms. H. pectinata oil was most effective against Gram (+) bacteria and yeasts. 
Keywords: Hyptis pectinata; antimicrobial activity; essential oil.
introdUCtion
Essential oils from aromatic plant species are used in industry 
for the production of soaps, perfumes and toiletries. Many have been 
used in developing countries as alternative treatments for various 
health problems.1 
The Hyptis genus of the Lamiaceae family includes around 400 
species distributed throughout the Americas, West Africa, Fiji Island 
(Oceania), and western India. They are found in northern Brazil. The 
members of this genus have high economic importance because they 
are a source of aromatic essential oil, and are also used for landscape 
gardening and culinary purposes.2 However, ethno-pharmacological 
features and chemical compositions have only been studied for 25 
species.2,3
Hyptis pectinata (L.) Poit., popularly known in Brazil as “samba-
caitá” or “canudinho”, is an herbaceous plant with aromatic leaves, 
and small bilabial flowers,4 used extensively in traditional medicine 
by local populations for the treatment for conditions including 
rhinopharyngitis, nasal congestion, skin diseases, gastric disorders, 
fever, and various bacterial and fungal infections.5 H. pectinata has 
also been extensively used in mouth rinses by the population of the 
state of Sergipe, Brazil.3
Earlier work has investigated the pharmacological properties 
of H. pectinata in the forms of essential oil, aqueous extract, me-
thanolic extract or leaves. Bispo et al.4 and Lisboa et al.5 reported 
antinociceptive and antiedematogenic action of the aqueous extract, 
with low toxicity. Mélo et al.6 identified a promoter effect on liver 
regeneration following partial hepatectomy. Although there have been 
a limited number of investigations of the bioactivity of H. pectinata, 
information concerning the antibacterial and antifungal properties 
of the essential oil is scarce. Malan7,8 reported high antifungal and 
antibacterial activity and, more recently, Fragoso-Serrano et al.9 noted 
in vitro anti-staphylococcal activity from the isolated pectinolides A, 
B, C and H. Oils from several Lamiaceae species have been tested 
for their antibacterial properties, with all species being shown to be 
effective in reducing growth of the bacteria tested.10 The aim of the 
present work was to determine the chemical composition and eva-
luate the antimicrobial activity of the essential oil of H. pectinata, 
cultivated in Sergipe state, Brazil, against reference strains of Gram 
(+) and Gram (-) bacteria, and yeasts (Candida genus and Crypto-
coccus neoformans).
eXperimental 
plant material
Cultivation of Hyptis pectinata was undertaken at the Federal 
University of Sergipe (UFS) Experimental Farm, São Cristóvão, 
Sergipe, Brazil (10o 18’ 20.7” (S); 36o 39’ 7.2” (W) and 120 m above 
sea level). Leaves were collected from plants of H. pectinata accession 
SAM0012, of the germ plasm bank at UFS. A reference specimen 
was deposited at the UFS herbarium (registry number 7454). Lea-
ves were dried in an oven (at 40 °C) for a period of 5 days, with air 
renewal and circulation, until complete dehydration was achieved, 
then ground to a coarse powder.
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essential oil extraction 
The essential oil was obtained by hydrodistillation (for 3 h) of 
H. pectinata leaves in a Clevenger-type apparatus, until no more 
condensing oil could be seen. The essential oil was separated from 
the aqueous solution (hydrolate), dried with anhydrous Na2SO4 
(yield 0.5% v/w), transferred to an amber glass flask, and kept at a 
temperature of –10 °C until used.
Gas chromatography – mass spectrometry (GC-ms) and gas 
chromatography (GC-fid)
Oil sample analysis was performed on a Shimadzu QP5050A 
gas chromatograph (Shimadzu Corporation, Kyoto, Japan), inter-
faced to a mass spectrometer (GC-MS). The following conditions 
were used: DB5 column (30 cm x 0.25 mm i.d., 5% phenylm-
ethylpolysiloxane); helium (99.999%) carrier gas at a constant 
flow of 1.2 mL min-1; 0.5 μL injection volume (in ethyl acetate); 
injector split ratio of 1:20; injector temperature 250 °C; electron 
impact mode at 70 eV; ion-source temperature 280 °C. The oven 
temperature was programmed from 80 °C (isothermal for 2 min), 
with an increase of 3 °C min-1 to 180 °C, then 10 °C min-1 to 300 
°C, and 10 min isothermal at 300 °C. Mass spectra were taken at 
70 eV, with a scan interval of 0.5 s, and considered ion fragments 
in the range 40 to 450 Da. 
Quantitative analysis of the chemical constituents was performed 
using a Shimadzu GC-17A flame ionization gas chromatograph 
(GC-FID). A fused silica ZB5 capillary column (5% phenyl, 95% 
dimethylpolysiloxane, 30 m x 0.25 mm i.d., 0.25 μm fi lm thick-
ness) was employed (Phenomenex, Torrance, CA, USA), under the 
same conditions as the GC-MS procedure. Quantification of each 
constituent was estimated by area normalization (%). Compound 
concentrations were calculated from the GC peak areas, and arranged 
in order of elution.
identification of essential oil constituents
A mixture of linear hydrocarbons (C9H20 – C19H40) was injected 
under the same conditions as samples, and identification of consti-
tuents performed by comparing the spectra obtained with those of 
the equipment’s database (NIST 21 and NIST 107), and by using 
the Kovats Index, calculated for each constituent as previously 
described.11
isolation and characterization of calamusenone (2,3,4,5,7,8-
hexahydro-1.4-dimethyl-7-(1-methylethylidene)-6(1h)-
azulenone)
The oil was diluted in 1.0 mL of ethyl acetate and applied to a 
preparative thin layer chromatography plate (10 x 20 cm) coated with 
2 mm of silica gel (60 PF254). The plate was eluted twice with hexane, 
followed by elution with hexane/ethyl acetate (95:5). After elution, 
the plate was observed using ultraviolet light (Vilber Lourmat) at a 
wavelength of 254 nm and Rf range of 0.41 to 0.54. The plate was 
extracted using ethyl acetate, the extract filtered, and the solvent 
removed using a rotary evaporator operated at 40 oC. The residue 
contained the calamusenone (34 mg, 34%). NMR spectra, obtained 
using a Bruker instrument, and characterized by 1H NMR (CDCl3, 
400 MHz) and 13C NMR (CDCl3, 100 MHz), were consistent with 
previously reported data for calamusenone12 (Figure 1). The EI-MS 
mass spectrum of calamusenone contains: m/z 218 (M+, 100%), m/z 
203 (24%), m/z 175 (31%), m/z 161 (51%), m/z 133 (53%), m/z 105 
(76%), m/z 83 (49%) and m/z 41 (66%). 
antimicrobial activity
The microorganisms tested were the yeasts Candida albicans 
(ATCC 1884), Candida guilhermondii (ATCC 6260), Candida du-
bliniensis (MYA-646), Candida parapsilosis (ATCC 22019), Crypto-
coccus neoformans (IOC 7523), and the bacteria Citrobacter freundii 
(ATCC 8090), Salmonella enteritidis (ATCC 25928), Bacillus subtilis 
(ATCC 6633), Escherichia coli (ATCC 1284), Pseudomonas aerugi-
nosa (ATCC 1238), Serratia marcescens (ATCC 13880), Klebsiella 
pneumoniae (ATCC 13883), Enterobacter cloacae (ATCC 13640), 
Enterococcus faecalis (ATCC 29212), Staphylococcus aureus (ATCC 
12600) and Staphylococcus epidermidis (ATCC 12228).
minimal inhibitory concentration (miC) and minimal 
microbicidal concentration (mmC) assays
Inhibition of microorganism growth was determined using a micro 
dilution assay in a sterile 96-well micro titre plate.13,14 H. pectinata 
essential oil was tested at concentrations ranging from 0.5 to 300 
mg mL-1 (diluted in 0.5% DMSO according to CLSI M7-A615 and 
M27-A216). 
Each well contained 100 μL of twofold serially diluted essential 
oil, 95 μL of double strength BHI growth medium (bacteria) or RPMI 
1640 (yeasts), and 0.5 μL of an overnight culture of each strain, 
representing, approximately, 5 x 104 bacterial cells mL-1 and 2.5 x 
103 yeast cells mL-1.
The controls comprised pure growth medium, or inoculated 
growth medium, without the test agent. The plates were incubated 
at 37 ºC for 24 h (bacteria) or 37 ºC for 48 h (yeasts), except Crypto-
coccus neoformans, which was incubated for 72 h. The results were 
based on visible growth or inhibition. The plate was shaken for 30 
s before each reading.
The MIC was defined as the minimum concentration of the test 
agent which caused >80% growth inhibition, compared to untreated 
cultures. 
minimal bactericidal concentration (mbC) and minimal 
fungicidal concentration (mfC)
To assess whether the action of the essential oil was microbios-
tatic or microbicidal, 100 μL of the microbial culture were taken 
from concentrations equal to, or higher than, the MIC, streaked on 
BHI or Sabouraud agar plates, and incubated at 37 oC for 48 h (ex-
cept Cryptococcus neoformans, which was incubated for 72 h). No 
growth at concentrations higher than, or equal to, the MIC indicated 
microbicidal action. Control tests were run simultaneously by adding 
solvents without the essential oil. All experiments were undertaken 
in duplicate, and average values were calculated.
Figure 1. Structural formula of the guaiane-type sesquiterpene derivative 
2,3,4,5,7,8-hexahydro-1,4-dimethyl-7-(1-methylethylidene)-6(1H)-azulenone 
(calamusenone), the dominant compound identified in the essential oil of H. 
pectinata
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resUlts and disCUssion
The composition and relative percentages of compounds in the 
essential oil were determined (Table 1). Twenty-one compounds 
were found. Twenty (98.85%) were identified as sesquiterpenoids, 
with high contents of calamusenone (24.64%), b-caryophyllene 
(18.34%) and caryophyllene oxide (18%). However, the chemical 
composition of H. pectinata essential oil is variable, and some authors 
have reported different results. Malan et al.8 investigated the chemical 
composition of H. pectinata from West Africa, and found that thy-
mol and p-cymene were the major components. Tchoumbougnang 
et al.17 identified germacrene D and b-caryophyllene as the major 
constituents. Pietschmann et al.18 compared three H. pectinata oils 
from different origins, and found that the major components were 
sabinene and caryophyllene (Indian oil), p-cymene (West African 
oil), and b-caryophyllene followed by b-elemene (Fiji island oil). 
These differences may be due to intra-species genetic variation, or to 
other factors including management style, climate, soil type, season, 
type of material (fresh or dry), extraction technique or geographical 
location (latitude and altitude).19-22
The high sesquiterpene content of Hyptis pectinata essential oil 
from Sergipe, particularly the high percentage of b-caryophyllene, 
is a common feature of essential oils.14,17,18 Almeida et al.23 highlight 
many studies which report on the antimicrobial properties of essential 
oils containing a significant sesquiterpene fraction. Essential oils 
rich in sesquiterpenes present biological properties which include 
spasmolytic,24 local anaesthetic,25 anti-inflammatory,26 antimicrobial23 
and antifungal action.27
Calamusenone, the major component found here, is frequently 
isolated from Acorus calamus,17,28 a semi-aquatic plant of the Araceae 
family found in central Asia, India, North America and Europe. This 
compound is not well researched, and there exist few data in the lite-
rature concerning its biological activity. According to Hu and Feng,29 
Acorus calamus is used in “Chang-Pu” traditional Chinese medicine 
for treatment of dementia. The herbal medicine product includes the 
roots of three major Acorus species (A. calamus L., A. gramineus 
Soland and A. tatarinowii Schott). Calamusenone has recently been 
isolated from A. tatarinowii.29
Since this compound had not yet been previously isolated from 
plants of the Hyptis genus, and because there is a large genetic dis-
tinction between Acorus and Hyptis, we performed its isolation, and 
identification using NMR and retention index, and compared our 
findings with those reported for A. calamus.28,30
The 1H NMR 400 MHz spectra revealed δ 98 (1H, 17 Hz), δ 
2.72 (2H, 17 Hz), δ 1.06 (3H, 7 Hz) and δ 1.05 (3H, 7 Hz), with 5 
multiplets, δ 1.5 (1H), δ 2.2 (2H), δ 2.47 (1H), δ 2.60 (1H) and δ 
2.69 (1H) (Table 3). The 13C NMR spectral analysis indicated the 
existence of 15 carbon atoms. Of these, four were not hydrogenates 
(C), two were mono-hydrogenates (CH), four were di-hydrogenates 
(CH2), four were tri-hydrogenates (CH3), and one was carbonylic 
carbon (CO). Table 2 indicates the similarity between the present 
data and those reported in the literature for calamusenone isolated 
from A. calamus.
Many authors have demonstrated the antimicrobial activity of 
essential oils. Oliveira et al.31 showed that Lippia origanoides es-
sential oil was effective against Candida spp., S. aureus, S. mutans, 
and other microorganisms. Nascimento et al.3 demonstrated the anti-
Streptococcus mutans activity of H. pectinata, using its essential oil 
rich in caryophyllene oxide (28%) and caryophyllene (28.3%).
Some studies have concluded that whole essential oils possess 
greater antibacterial activity than the mixed major components,32,33 
which suggests that the minor components might be critical to such 
activity, due to synergistic (or other) effects.
In the present study, the antimicrobial and microbicidal potentials 
of H. pectinata essential oil (Table 3) were tested using Gram (+) 
and Gram (-) bacteria, and standard strains of yeast from the ATCC 
(American Typing Culture Collection) and IOC (Instituto Oswaldo 
Cruz, Rio de Janeiro) collections. Negative MIC values were ob-
tained for the yeasts and the Gram (+) bacteria. The most sensitive 
yeasts were C. albicans (MIC = 0.58 mg mL-1), C. neoformans (MIC 
table 1. Chemical compounds present in Hyptis pectinata essential oil
Peak RT (min) Compound (%) RRI exp.a RRI lit. b
1 4.050 α-Pinene 1.39 937 939
2 4.700 1-Octen-3-ol 2.23 975 979
3 4.817 b-Pinene 6.95 982 980
4 5.867 Limonene 2.06 1030 1031
5 7.550 Linalool 1.54 1099 1098
6 16.375 α-Copaene 2.40 1381 1376
7 16.867 b-Elemene 2.15 1396 1391
8 17.800 b-Caryophyllene 18.34 1425 1419
9 18.900 α- Humulene 1.50 1459 1455
10 19.758 Germacrene-D 3.07 1486 1485
11 20.050 cis-b-Guaiane 3.76 1495 1493
12 20.258 Bicyclogermacrene 1.49 1502 1500
13 20.525 b-Bisabolene 1.17 1510 1506
14 20.758 γ-Cadinene 1.75 1518 1514
15 21.025 trans-Calamene 2.40 1527 1529
16 21.958 epi-Longipenol 1.07 1558 1564
17 22.708 Globulol 1.24 1583 1583
18 22.892 Caryophyllene oxide 18.00 1589 1583
19 23.833 1,10-di-epi-Cubenol 1.66 1621 1619
20 25.767 Calamusenone 24.68 1677 1680c
aRRI = relative retention index using the Van den Dool equation.40 bAccording to ref. 11 cFrom ref. 30 
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= 1.17 mg mL-1) and C. dubliniensis (MIC = 3.12 mg mL-1). For 
the Gram (+) bacteria (S. aureus, S. epidermidis, B. subtilis and E. 
faecalis) tested in this work, the essential oil presented MIC values 
between 12.5 and 50 mg mL-1. S. aureus and B. subtilis presented 
the smallest MICs (12.5 mg mL-1), and E. faecalis the largest MIC 
(50 mg mL-1). The activity of H. pectinata essential oil against fungi 
and Gram (+) bacteria is in agreement with the findings of Almeida 
et al..23 Celiktas et al.34 obtained MIC values of 10 and 20 mg mL-1, 
respectively, for the Gram (+) bacteria S. aureus and S epidermidis, 
using Rosmarinus officinalis essential oil. Pereda-Miranda et al.35 
obtained MIC values of 6.25 and 12.5 μg mL-1 for the same bacteria, 
using the isolated pectinolides A and C (compounds present in H. 
pectinata essential oil). 
The oil was effective against the Gram (-) bacteria Klebsiella 
pneumoniae, Pseudomonas aeruginosa and Salmonella enteritidis. 
MIC values were 200, 200 and 300 mg mL-1, respectively. These 
are considered high, and were similar to the MBC. According to 
Mann et al.,36 Gram (-) bacteria may be less sensitive to essential 
oils due to their hydrophilic external layer, which restricts access of 
the hydrophobic oils. 
There is a current tendency not to consider MIC values above 
200 mg mL-1 as promising, however we disagree, for several reasons. 
table 2. 1H NMR and 13C NMR spectral data: A parallel between calamusenone isolated from Acorus calamusa and the sesquiterpene isolated 
from H. pectinata (access SAM003) essential oil. Chemical shifts (relative to TMS) in (δ) ppm, coupling constants in Hz (in parentheses), 
samples diluted in CDCl3
Carbon
1H NMR 13C NMR
A. calamus H. pectinata A. calamus H. pectinata
1 2.42 (1H, m) 2.47 (1H, m) 45.052 44.832
2 2.04 (2H, m) 2.02 (2H, m) 31.048 30.804
3 1.38 (1H, m) 1.35 (1H, m) 34.266 34.081
2.54 (1H, m) 2.60 (1H, m)
3a 138.789 138.797
4 2.68 (1H, m) 2.69 (1H, m) 33.372 33.169
5 2.77 (2H, d, 6 Hz) 2.72 (2H, d, 6 Hz) 48.926 48.736
6 204.640 205.343
7 134.474 134.537
8 2.95 (1H, d, 17 Hz) 2.98 (1H, d, 17 Hz) 27.353 27.110
3.17 (1H, d, 17 Hz) 3.09 (1H, d, 17 Hz)
8a 137.617 137.679
1´ 140.402 140.817
2´ 1.85 (3H, s) 1.82 (3H, s) 22.546 22.496
3´ 2.04 (3H, s) 2.03 (3H, s) 23.003 23.921
4´ 1.08 (3H, d, 7 Hz) 1.06 (3H, d, 7 Hz) 19.844 19.706
5´ 1.07 (3H, d, 7 Hz) 1.05 (3H, d, 7 Hz) 19.733 19.597
aRef. 12
table 3. Minimal inhibitory concentrations (MIC), minimal fungicidal concentrations (MFC), and minimal bactericidal concentrations (MBC) 
of H. pectinata essential oil
Microorganisms Gram +/- MIC (mg mL-1) MFC and MBC (mg mL-1)
Citrobacter freundii ATCC 8090 G- - -
Salmonella enteritidis ATCC 25928 G- 300 300
Escherichia coli ATCC 1284 G- - -
Pseudomonas aeruginosa ATCC 1238 G- 200 200
Serratia marcescens ATCC13880 G- - -
Klebsiella pneumoniae ATCC 13883 G- 200 200
Enterobacter cloacae ATCC13640 G- - -
Enterococcus faecalis ATCC 29212 G+ 50 100
Bacillus subtilis ATCC 6633 G+ 12.5 12.5
Staphylococcus aureus ATCC 12600 G+ 12.5 100
Staphylococcus epidermidis ATCC 12228 G+ 18.75 18.75
Neisseria gonorrhoeae ATCC 1942 G- 75 75
Candida albicans ATCC 18804 0.58 0.58
Candida guilhermondii ATCC 6260 12.5 25
Candida parapsilosis ATCC 22019 25 -
Candida dubliniensis ATCC MYA-646 3.12 3.12
Cryptococcus neoformans IOC 7523 1.17 1.17
Santos et al.1652 Quim. Nova
Essential oil activity may be related to many other factors, such as 
oil volatility, water solubility, and general chemical complexity.37 
Synergistic or antagonistic effects cannot be evaluated using in vitro 
tests.34,38 Hence, there is a clear need for further work, since natural 
products (such as extracts and essential oils), may, despite presenting 
only weak anti-pathogen performance, be used either as new drug 
prototypes, or in association with such products.39 
MFC values were similar to MIC, except for C. guilhermondii (MIC 
= 12.5 mg mL-1, MFC = 25 mg mL-1). These results may be indicative of 
the possibility of either a fungistatic or a fungicidal dose. The oil showed 
a MIC of 25 mg mL-1 against C. parapsilosis, however no concentra-
tion was able to kill this organism. We can conclude that H. pectinata 
essential oil is purely fungistatic with respect to this species.
ConClUsions
Chemical analysis of H. pectinata essential oil showed that sesqui-
terpenes were the main compounds present, followed by monoterpe-
nes. Of the sesquiterpenes, calamusenone was the major component. 
Other sesquiterpenes, such as caryophyllene and caryophyllene oxide, 
were also present at significant percentages. 
For the analytical conditions and microorganisms employed in 
this work, we can conclude that H. pectinata essential oil is more 
effective against yeasts and Gram (+) bacteria. It can only inhibit 
Gram-negatives at high concentrations. The essential oil shows mi-
crobicidal action against Gram (+) bacteria, however in the case of 
yeasts it can be considered either fungicidal or fungistatic, depending 
on dose or species. This activity can be attributed principally to the 
sesquiterpenes, such as b−caryophyllene and caryophyllene oxide, 
as well as other terpenes, which are known to possess antimicrobial 
properties. It is important to stress that synergistic action between 
different compounds is an important contributor to essential oil 
activity. Further work will be required to investigate the biological 
activity of the sesquiterpene, calamusenone.
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